HAL (France)open access
High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies
1, COVID-19, 0, Autoantibodies, Interferons, Myasthenia gravis
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 922934
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.